Skip to content
10-Q

Quarterly Report

GREEN VISION BIOTECHNOLOGY CORP.

0001640334-22-001104

← back to feed
Filed
May 23, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 23, 2022 160.79M sh
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$7.91K
Operating Cash Flow Q1 2022 · Mar 31, 2021 $7.5K
Cash And Equivalents Q1 2022 · Mar 31, 2022 $11.78K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $6.51K
Cash And Equivalents Q1 2022 · Mar 31, 2021 $231.55K
Cash And Equivalents Q1 2022 · Dec 31, 2020 $26.73K
Stockholders Equity Q1 2022 · Mar 31, 2022 −$9.05M
Stockholders Equity Q1 2022 · Jan 1, 2022 −$7.92M
Stockholders Equity Q1 2022 · Dec 31, 2021 −$7.92M
Stockholders Equity Q1 2022 · Mar 31, 2021 −$7.52M
Stockholders Equity Q1 2022 · Jan 1, 2021 −$7.41M
Current Liabilities Q1 2022 · Mar 31, 2022 $10.92M
Current Liabilities Q1 2022 · Dec 31, 2021 $10.84M
Total Liabilities Q1 2022 · Mar 31, 2022 $10.92M
Total Liabilities Q1 2022 · Dec 31, 2021 $10.84M
Current Assets Q1 2022 · Mar 31, 2022 $114.37K
Current Assets Q1 2022 · Dec 31, 2021 $29.78K
Total Assets Q1 2022 · Mar 31, 2022 $1.87M
Total Assets Q1 2022 · Dec 31, 2021 $2.92M
Net Income Q1 2022 · Mar 31, 2022 −$1.15M
Net Income Q1 2022 · Mar 31, 2022 −$1.15M
Net Income Q1 2022 · Mar 31, 2021 −$105.93K
Net Income restated Q1 2022 · Dec 31, 2020 −$499.78K
Operating Income Q1 2022 · Mar 31, 2022 −$130.36K
Operating Income Q1 2022 · Mar 31, 2021 −$106.89K
Gross Profit Q1 2022 · Mar 31, 2022 $0
Gross Profit Q1 2022 · Mar 31, 2021 $31.72K
Cost Of Revenue Q1 2022 · Mar 31, 2022 $0
Cost Of Revenue Q1 2022 · Mar 31, 2021 $32.75K
Revenue Q1 2022 · Mar 31, 2022 $0
Revenue Q1 2022 · Mar 31, 2021 $64.47K
Shares Diluted Q1 2022 · Mar 21, 2022 160.79M sh
Shares Diluted Q1 2022 · Mar 31, 2021 160.79M sh